Compugen (CGEN) Quick Ratio: History & Chart

Compugen Ltd.(CGEN)

Biotechnology · Holon, TA

$2.26-0.05 (-2.16%)

Delayed quote: Oct 6, 2026, 10:10 AM EDT

About Compugen Ltd.

Compugen Ltd., an Israeli-based company established in 1993 and headquartered in Holon, is a clinical-stage enterprise focused on the discovery, development, and commercialization of therapeutic and product candidates. Its operations extend across Israel, the United States, and Europe. The company’s core activities center around its immuno-oncology pipeline, which includes several investigational treatments: COM701, an anti-PVRIG antibody currently undergoing Phase I clinical studies for solid tumors. COM902, a therapeutic antibody designed to target TIGIT, which is also in Phase I clinical trials as a monotherapy for advanced malignancies. Bapotulimab, an antibody targeting ILDR2, presently in Phase I clinical development for solid tumor indications. AZD2936, an innovative bispecific antibody targeting both TIGIT and PD-1, advancing through Phase I/II clinical studies for patients with advanced or metastatic non-small cell lung cancer. Additionally, Compugen maintains earlier-stage immuno-oncology programs, with a particular emphasis on myeloid targets. To further its research and development, Compugen actively fosters strategic alliances. It has a collaboration agreement with Bayer Pharma AG for the research, development, and commercialization of antibody-based therapeutics that modulate immune checkpoint regulators. Another key partnership is with Bristol-Myers Squibb, aimed at evaluating the safety and tolerability of COM701 when administered alongside Bristol-Myers Squibb's PD-1 immune checkpoint inhibitor, Opdivo, in patients with advanced solid tumors. The company also collaborates with Johns Hopkins School of Medicine to investigate novel T cell and myeloid checkpoint targets, and has a distinct research collaboration with Johns Hopkins University specifically dedicated to myeloid science. Furthermore, Compugen holds a licensing agreement with AstraZeneca for the development of bi-specific and multi-specific immuno-oncology antibody products.

Holon, TA

75 employees

cgen.com

Healthcare / Biotechnology

Sector: Healthcare
Industry: Biotechnology
CEO: Eran Ophir

View full financials

CGEN Quick Ratio (Acid-Test) Metrics

QUICK RATIO (ACID-TEST)

5.72

QUICK RATIO (ACID-TEST) AVG TTM

5.53

QUICK RATIO (ACID-TEST) AVG 3Y

5.16

QUICK RATIO (ACID-TEST) AVG 5Y

6.01

QUICK RATIO (ACID-TEST) AVG 10Y

7.08

QUICK RATIO (ACID-TEST) AVG 15Y

10.33

QUICK RATIO (ACID-TEST) AVG 20Y

10.06

CURRENT VS TTM AVG

+3.46%

CURRENT VS 3Y AVG

+10.73%

CURRENT VS 5Y AVG

-4.89%

CURRENT VS 10Y AVG

-19.30%

CURRENT VS 15Y AVG

-44.64%

CURRENT VS 20Y AVG

-43.16%

SECTOR MEDIAN · HEALTHCARE

2.99

median of 563 covered companies

CURRENT VS SECTOR MEDIAN

+91.23%

vs the sector median at left

NAME	MARKET CAP	QUICK RATIO (ACID-TEST)	TTM	3Y	5Y
Compugen Ltd. (CGEN)	$213.69M	5.72	5.53	5.16	6.01
Lyell Immunopharma, Inc. (LYEL)vs ›	$217.72M	5.36	6.17	11.50	11.99
Alector, Inc. (ALEC)vs ›	$209.42M	5.26	3.62	4.54	4.95
Keros Therapeutics, Inc. (KROS)vs ›	$227.22M	21.96	18.45	17.11	21.15
Electra Therapeutics Inc. (ETRA)vs ›	$202.05M	N/A	N/A	N/A	N/A
MacroGenics, Inc. (MGNX)vs ›	$234.38M	2.96	4.42	4.46	4.62
BioAge Labs Inc. (BIOA)vs ›	$234.93M	17.19	13.55	8.08	8.08
Akebia Therapeutics, Inc. (AKBA)vs ›	$236.90M	1.35	1.13	1.14	1.18
Eledon Pharmaceuticals, Inc. (ELDN)vs ›	$195.29M	7.90	9.91	10.86	18.34
High Tide Inc. (HITI)vs ›	$240.32M	0.81	0.81	0.76	0.71

NAME

MARKET CAP

QUICK RATIO (ACID-TEST)

TTM

Compugen Ltd. (CGEN)

$213.69M

5.72

5.53

5.16

6.01

Lyell Immunopharma, Inc. (LYEL)vs ›

$217.72M

5.36

6.17

11.50

11.99

Alector, Inc. (ALEC)vs ›

$209.42M

5.26

3.62

4.54

4.95

Keros Therapeutics, Inc. (KROS)vs ›

$227.22M

21.96

18.45

17.11

21.15

Electra Therapeutics Inc. (ETRA)vs ›

$202.05M

N/A

MacroGenics, Inc. (MGNX)vs ›

$234.38M

2.96

4.42

4.46

4.62

BioAge Labs Inc. (BIOA)vs ›

$234.93M

17.19

13.55

8.08

Akebia Therapeutics, Inc. (AKBA)vs ›

$236.90M

1.35

1.13

1.14

1.18

Eledon Pharmaceuticals, Inc. (ELDN)vs ›

$195.29M

7.90

9.91

10.86

18.34

High Tide Inc. (HITI)vs ›

$240.32M

0.81

0.76

0.71

Quick Ratio (Acid-Test) FAQ

What is the quick ratio (acid-test) for Compugen Ltd. (CGEN)?

The quick ratio (acid-test) for CGEN stock is 5.72.

Is Compugen Ltd.'s quick ratio (acid-test) high or low?

The quick ratio (acid-test) of 5.72 is in line with its 5-year average of 6.01, near the low end of its 5-year range (4.12–9.60).

What is the TTM average quick ratio (acid-test) for Compugen Ltd. (CGEN)?

The TTM average quick ratio (acid-test) for CGEN stock is 5.53.

What is the 3Y average quick ratio (acid-test) for Compugen Ltd. (CGEN)?

The 3Y average quick ratio (acid-test) for CGEN stock is 5.16.

What is the 5Y average quick ratio (acid-test) for Compugen Ltd. (CGEN)?

The 5Y average quick ratio (acid-test) for CGEN stock is 6.01.

What is the 10Y average quick ratio (acid-test) for Compugen Ltd. (CGEN)?

The 10Y average quick ratio (acid-test) for CGEN stock is 7.08.

What is the 15Y average quick ratio (acid-test) for Compugen Ltd. (CGEN)?

The 15Y average quick ratio (acid-test) for CGEN stock is 10.33.

What is the 20Y average quick ratio (acid-test) for Compugen Ltd. (CGEN)?

The 20Y average quick ratio (acid-test) for CGEN stock is 10.06.

DATE	QUICK RATIO (ACID-TEST)
2026-06-30	5.72
2026-03-31	6.23
2025-12-31	6.56
2025-09-30	4.38
2025-06-30	4.74
2025-03-31	5.09
2024-12-31	5.26
2024-09-30	4.14
2024-06-30	4.12
2024-03-31	4.29
2023-12-31	4.36
2023-09-30	5.81
2023-06-30	6.43
2023-03-31	7.13
2022-12-31	7.23
2022-09-30	6.16
2022-06-30	7.29
2022-03-31	7.14
2021-12-31	7.21
2021-09-30	7.36
2021-06-30	9.60
2021-03-31	10.65
2020-12-31	12.27
2020-09-30	16.93
2020-06-30	17.01
2020-03-31	14.04
2019-12-31	6.60
2019-09-30	7.19
2019-06-30	5.38
2019-03-31	5.11
2018-12-31	4.80
2018-09-30	4.61
2018-06-30	5.92
2018-03-31	5.81
2017-12-31	5.31
2017-09-30	6.72
2017-06-30	9.38
2017-03-31	10.63
2016-12-31	13.66
2016-09-30	14.90
2016-06-30	16.73
2016-03-31	14.32
2015-12-31	13.54
2015-09-30	14.99
2015-06-30	18.68
2015-03-31	13.09
2014-12-31	11.53
2014-09-30	21.55
2014-06-30	17.20
2014-03-31	14.56
2013-12-31	6.96
2013-09-30	5.63
2013-06-30	16.21
2013-03-31	17.10
2012-12-31	18.85
2012-09-30	23.26
2012-06-30	14.68
2012-03-31	24.16
2011-12-31	13.48
2011-09-30	31.91
2011-06-30	19.99
2011-03-31	32.50
2010-12-31	11.50
2010-09-30	18.38
2010-06-30	38.41
2010-03-31	29.34
2009-12-31	16.43
2009-09-30	7.82
2009-06-30	8.60
2009-03-31	6.80
2008-12-31	4.05
2008-09-30	4.20
2008-06-30	4.50
2008-03-31	6.64
2007-12-31	5.52
2007-09-30	5.45
2007-06-30	10.00
2007-03-31	11.46
2006-12-31	8.90
2006-09-30	11.75
2006-06-30	12.88
2006-03-31	10.83
2005-12-31	8.55
2005-09-30	13.67
2005-06-30	9.09
2005-03-31	10.18
2004-12-31	6.37
2004-09-30	8.41
2004-06-30	7.56
2004-03-31	6.43
2003-12-31	3.38
2003-09-30	3.13
2003-06-30	7.06
2003-03-31	7.65
2002-12-31	8.10
2002-09-30	9.23

DATE

QUICK RATIO (ACID-TEST)

2026-06-30

5.72

2026-03-31

6.23

2025-12-31

6.56

2025-09-30

4.38

2025-06-30

4.74

2025-03-31

5.09

2024-12-31

5.26

2024-09-30

4.14

2024-06-30

4.12

2024-03-31

4.29

2023-12-31

4.36

2023-09-30

5.81

2023-06-30

6.43

2023-03-31

7.13

2022-12-31

7.23

2022-09-30

6.16

2022-06-30

7.29

2022-03-31

7.14

2021-12-31

7.21

2021-09-30

7.36

2021-06-30

9.60

2021-03-31

10.65

2020-12-31

12.27

2020-09-30

16.93

2020-06-30

17.01

2020-03-31

14.04

2019-12-31

6.60

2019-09-30

7.19

2019-06-30

5.38

2019-03-31

5.11

2018-12-31

4.80

2018-09-30

4.61

2018-06-30

5.92

2018-03-31

5.81

2017-12-31

5.31

2017-09-30

6.72

2017-06-30

9.38

2017-03-31

10.63

2016-12-31

13.66

2016-09-30

14.90

2016-06-30

16.73

2016-03-31

14.32

2015-12-31

13.54

2015-09-30

14.99

2015-06-30

18.68

2015-03-31

13.09

2014-12-31

11.53

2014-09-30

21.55

2014-06-30

17.20

2014-03-31

14.56

2013-12-31

6.96

2013-09-30

5.63

2013-06-30

16.21

2013-03-31

17.10

2012-12-31

18.85

2012-09-30

23.26

2012-06-30

14.68

2012-03-31

24.16

2011-12-31

13.48

2011-09-30

31.91

2011-06-30

19.99

2011-03-31

32.50

2010-12-31

11.50

2010-09-30

18.38

2010-06-30

38.41

2010-03-31

29.34

2009-12-31

16.43

2009-09-30

7.82

2009-06-30

8.60

2009-03-31

6.80

2008-12-31

4.05

2008-09-30

4.20

2008-06-30

4.50

2008-03-31

6.64

2007-12-31

5.52

2007-09-30

5.45

2007-06-30

10.00

2007-03-31

11.46

2006-12-31

8.90

2006-09-30

11.75

2006-06-30

12.88

2006-03-31

10.83

2005-12-31

8.55

2005-09-30

13.67

2005-06-30

9.09

2005-03-31

10.18

2004-12-31

6.37

2004-09-30

8.41

2004-06-30

7.56

2004-03-31

6.43

2003-12-31

3.38

2003-09-30

3.13

2003-06-30

7.06

2003-03-31

7.65

2002-12-31

8.10

2002-09-30

9.23

Quick Ratio (Acid-Test): 5.72

CGEN Quick Ratio

CGEN Average Quick Ratio (Acid-Test) Chart

CGEN Current vs Average Quick Ratio (Acid-Test) Chart

CGEN Quick Ratio (Acid-Test) Metrics

CGEN Competitors' Quick Ratio (Acid-Test)

Liquidity Comparison

Quick Ratio (Acid-Test) Formula & Definition

Quick Ratio (Acid-Test) FAQ

CGEN Quick Ratio (Acid-Test) History

Related Metrics